We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 167.50
Bid: 165.00
Ask: 170.00
Change: 12.50 (8.06%)
Spread: 5.00 (3.03%)
Open: 155.00
High: 167.50
Low: 155.00
Prev. Close: 155.00
HUW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Syndicate Mid-Point Forecasts

30 Aug 2023 07:00

RNS Number : 7221K
Helios Underwriting Plc
30 August 2023
 

30th August 2023

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Quarterly Syndicate Mid-Point Forecasts

 

Indicative underwriting profits of 22p per share to be recognised over the next two years

Potential NTA per share of 174p

 

Helios, the investment vehicle which builds shareholder value through exposure to Lloyd's, announces the current mid-point forecasts in respect of its portfolio of syndicate capacity for the 2021 and 2022 years of account based on 2nd quarter 2023 mid-point estimates.

 

Martin Reith, Chief Executive, commented:

 

"Helios' proposition as the investment vehicle which builds shareholder value through exposure to Lloyd's continues to go from strength to strength. We have built and curated an outstanding portfolio of the better performing syndicates, based on stringent underwriting discipline and judicious capital deployment. During the period, we have acquired four further LLVs, and taken £6m capacity on a new syndicate.

 

"Market conditions at Lloyd's are strong, as reflected in our second published mid-point profit forecast for 2022 of 5.7% of capacity. This, compounded by Helios' increased retained capacity, £184m for the 2022 year of account, leads us to be confident in our expectation of achieving underwriting profits of 22p per share over the next two years."

 

2021

2022

2023

 

£m

£m

£m

Total capacity as at 30th May 2023

 

Retained

99.3

177.6

238.4

Reinsured

51.5

60.8

58.3

 

150.8

238.4

296.7

Changes since 30th May

 

Acquisition of LLV's

6.4

6.8

8.1

New Syndicate Participation

-

-

6.0

Increase in capacity reinsured

-

-

(8.0)

Total change in retained

6.4

6.8

6.1

Reinsured

-

-

8.0

Total increase in capacity

6.4

6.8

14.1

 

 

Total capacity as at 30th August 2023

 

Retained

105.7

184.4

244.5

Reinsured

51.5

60.8

66.3

157.2

245.2

310.8

Mid-point forecast at 31st March 2023

3.9%

5.7%

Current mid-point forecast

4.9%

5.7%

 

Impact on Net Asset Value per share

£m

 

After tax retained underwriting losses earned to 31/12/2022 for 2021 & 2022 underwriting years

(4.8)

Indicative after tax retained underwriting profits from mid-point estimates

11.6

After tax retained underwriting profits to be earned

16.4

Potential increase in Net Tangible Asset Value per share - pence

22p

Current Net Tangible Asset Value per share

152p

Potential Net Asset Value per share

174p

 

Activity During the Period

 

Four LLV acquisitions have been completed, for a total consideration of £7.4m, adding capacity to all three open years of account.

 

We have taken £6m capacity on a new syndicate, commencing underwriting on 1st July 2023. Syndicate 1996 - managed by Wild fire Defence Systems - underwrites property in the USA that is susceptible to fire risk.

 

The capacity ceded to reinsurers was increased by £8m with effect from 1st January 2023 releasing Helios Funds at Lloyds' of £3.6m to be used for corporate purposes.

 

The 2021 mid-point estimate continues to improve to 4.9% (3.9% as at Q1 2023) in line with expectations.

 

The 2022 mid-point forecast at 5.7% profit on capacity (5.7% as at Q1 2023), after the impact of the loss from Hurricane Ian, will make a significant contribution to the earned underwriting profits in the future as this underwriting year recognised a loss in the first 12 months of 4.0%. 

 

The future retained after tax underwriting profits that are currently expected to be recognised over the next two years could increase the NTA per share by 22p to 174p per share. 

 

Notes

1) The table above shows the capacity as at 30th August 2023, splitting the capacity retained by Helios and the capacity that is ceded to quota share reinsurers. 

2) The mid-point forecasts for 2021 and 2022 years of account as at 2nd quarter 2023 have been aggregated at syndicate level from estimates supplied by Managing Agents.

3) The potential increase in net tangible asset value per share could be impacted by future underwriting losses, operating and reinsurance costs.

4) The impact on Helios will be as follows:

a. The underwriting profits to be recognised after 1 January 2023 on the retained capacity from the indications provided by the mid-point forecasts will be earned in calendar years 2023 and 2024.

b. The overall change in the syndicate results will be recognised by Helios in cash at the close of the year of account.

 

For further information, please contact:

Helios Underwriting plc

 

Helios Underwriting plc

Martin Reith - Chief Executive +44(0)7720 292 505

Nigel Hanbury - Executive Deputy Chairman +44(0)7787 530 404

Arthur Manners - Chief Financial Officer +44(0)7754 965 917

 

Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar +44 (0)20 7260 1000

 

Buchanan (PR)

Helen Tarbet / George Beale +44 (0)7872 604 453

+44 (0)20 7466 5111

 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately £311m of capacity for the 2023 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCPPUQPRUPWGBB
Date   Source Headline
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20237:00 amRNSTransaction in Own Shares
20th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20234:31 pmRNSShare Repurchase Programme
15th Dec 20237:30 amRNSHelios grows 2024 portfolio to over £500m capacity
11th Dec 202310:03 amRNSTransaction in Own Shares
11th Dec 20239:59 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSNet Asset Value as at 30 September 2023
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
1st Dec 20237:01 amRNSTransaction in Own Shares
1st Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:44 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSTransaction in Own Shares
27th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSCapacity Value Update
7th Nov 202312:43 pmRNSNotification of Major Holdings
7th Nov 202312:38 pmRNSTransaction in Own Shares
7th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
27th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSDividend Policy & Share Repurchase Programme
4th Oct 202310:50 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.